Dl. Wood et al., INHIBITION OF MITOSIS AND MICROTUBULE FUNCTION THROUGH DIRECT TUBULINBINDING BY A NOVEL ANTIPROLIFERATIVE NAPHTHOPYRAN LY290181, Molecular pharmacology, 52(3), 1997, pp. 437-444
The mechanism of action of a novel antiproliferative compound LY290181
(3-pyridyl)-4H-naphtho(1,2-b)pyran-3-carbonitrile] was characterized.
LY290181 is a potent inhibitor of cell proliferation, producing 50% i
nhibition of vascular smooth muscle, endothelial, Chinese hamster ovar
y, HeLa, and human erythroleukemia cells at concentrations of 8-40 nM.
Cell cycle analysis showed that LY290181 caused accumulation of smoot
h muscle cells at the G(2)/M phase and induced mitotic arrest in Chine
se hamster ovary cells and HeLa cells. At low concentrations (3-30 nM)
, LY290181 blocked transition of cells from metaphase to anaphase and
disrupted mitotic spindle organization. At high concentrations (greate
r than or equal to 100 nM), LY290181 produced a concentration-dependen
t loss of cytoplasmic and spindle microtubules. LY290181 inhibited the
polymerization of purified bovine brain microtubule protein into micr
otubules, and it depolymerized preformed microtubules. Using tubulin-1
-anilino-8-naphthalene sulfonate complex fluorescence, we have shown t
hat LY290181 directly interacted with tubulin in a unique manner. Thes
e studies show that LY290181 induces cell growth arrest in prometaphas
e/metaphase, and tubulin appears to be its molecular target.